Rheumatic arthritis. 48 (12): 3464-74. doi:10.1002/art.11365
페이지 정보
작성자 Savannah 작성일 25-03-26 17:09 조회 187회 댓글 0건본문
In 2013, biotime, a biotechnology and regenerative medicine company (amex: btx), acquired geron's stem cell-related assets under terms operations with promotions https://StemTreatmentCost.com/ having set the goal of resuming clinical studies.